The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of perioperative chemotherapy + avelumab in locally advanced gastroesophageal adenocarcinoma: Preliminary results.
 
Thierry Alcindor
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Eisai; Lilly; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer/EMD Serono; Roche Canada; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); Deciphera (Inst); EMD Serono (Inst); Epizyme (Inst); Karyopharm Therapeutics (Inst); SpringWorks Therapeutics (Inst)
 
Touhid Opu
No Relationships to Disclose
 
Arielle Elkrief
No Relationships to Disclose
 
Farzin Khosrow-Khavar
No Relationships to Disclose
 
Carmen L. Mueller
No Relationships to Disclose
 
Jonathan Cools-Lartigue
No Relationships to Disclose
 
Marc Hickeson
No Relationships to Disclose
 
Giovanni Artho
No Relationships to Disclose
 
Gertruda Evaristo
No Relationships to Disclose
 
Victoria Marcus
No Relationships to Disclose
 
Sophie Camilleri-Broët
No Relationships to Disclose
 
Pierre-Olivier Fiset
No Relationships to Disclose
 
Alan Spatz
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; Merck; Novartis; Pfizer/EMD Serono; Roche
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst)
 
Zoe Koulouris
No Relationships to Disclose
 
Lorenzo Ferri
No Relationships to Disclose